Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
AssigneeSinphar Tian-Lipharmaceutical Co., Ltd. (Hangzhou)
InventorsMuh-Hwan Su, Jing Jing Justine Tang, Hang-Ching Lin
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition for the treatment and prophylaxis of angina and myocardial infarction, wherein a combination of a tea extract (catechins) and an antianginal drug are proved therapeutically potent in treating angina and mycocardial infarction induced from myocardial ischemia. The present invention also provides a use of a tea extract (catechins) in treating and preventing angina.
Claims23
1-14. (canceled)
A method of using a compound of catechins in the treatment and prophylaxis of a disorder induced from myocardial ischemia, which comprises administering to a subject in need thereof an effective amount of a compound of catechins, wherein the disorder induced from myocardial ischemia is angina or myocardial infarction.
Dependencies are inferred from the claim text.